Business Standard
The S&P BSE Sensex fell by 780 points or 1.07 per cent to hit an intraday low of 71,882.90 on May 13
VIP Industries declined 3.59% to Rs 508.80 after the company reported consolidated net loss of Rs 23.88 crore in Q4 FY24 as against net loss of Rs 4.2
BEML's order book as on April 01, 2024, stood at Rs 11,872 crore as against Rs 8,570 crore in the previous year, an increase of 38.5 per cent.
ABB India Ltd, Esab India Ltd, Sharda Cropchem Ltd and Piramal Pharma Ltd are among the other gainers in the BSE's 'A' group today, 13 May 2024.
The first phase of Lok Sabha polls 2024 took place on April 19. The Nifty plunged 1 per cent in intra-day deals, but eventually ended 0.7 per cent hig
Gold Exchange Traded Fund (ETF) witness a net outflow of Rs 396 crore last month, making it the first withdrawal after March 2023, owing to profit boo
Foreign investors pulled out a massive Rs 17,000 crore from Indian equities in the first 10 days of the month owing to general election and the uncert
The combined market valuation of six of the top-10 most valued firms eroded by Rs 1,73,097.59 crore last week, with HDFC Bank and Life Insurance Corpo
Stock markets will be driven by domestic inflation data, ongoing quarterly earnings from corporates and global trends this week, analysts said. News
The price of 22-carat gold inched up Rs 10, with the yellow metal selling at Rs 67,560
Shares gaining investor interest post robust results, dividend of Rs 90 per share
Even average deal sizes of key domestic PE players like Kedara and CrysCapital doubled to $100 million in 2023 from $50 million in 2019
The second action against SMEs within a week for manipulation, issues caution to retail investors
The selling by FPIs has come at a time when traders are increasingly anxious about the margin of victory of the incumbent Narendra Modi government in
With over two decades of experience in the BPM industry, specifically in the Media, Entertainment, Gaming, and Trust & Safety sectors, Akash brings a
Mirabegron ER Tablets, 25 mg are a generic equivalent of Myrbetriq Extended-Release Tablets, 25 mg of Astellas Pharma Global Development, Inc., and we
Tata Motors reported a consolidated net profit of Rs 17,528.59 crore in Q4 FY24, steeply higher from Rs 5,496.04 crore posted in Q4 FY23.
Stocks ended the session on a high note, mirroring positive global trends. The Nifty 50 clawed its way back above 22,050, fueled by gains in metals an
In line with GPL's commitment to become carbon neutral by 2030, this investment will enhance the share of renewable power in its operation. The acquis
The offer received bids for 178.64 crore shares as against 7 crore shares on offer.
